Literature DB >> 10598919

Thrombolysis for acute stroke.

P D Lyden1.   

Abstract

Thrombolysis for acute stroke is effective if administered according to the approved protocol. Since the initial report of success in 1995, a number of subsequent reports confirmed the safety and efficacy of this treatment. There is no particular subgroup of patients at increased likelihood of benefit or hemorrhage that can be identified at baseline. Unlike many expensive therapies, thrombolysis for acute stroke saves the health care system considerable long-term costs. The search for even safer and more effective thrombolytics continues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598919     DOI: 10.1016/s0033-0620(99)70001-0

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  2 in total

1.  Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.

Authors:  C Iadecola; K Niwa; S Nogawa; X Zhao; M Nagayama; E Araki; S Morham; M E Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury.

Authors:  Yuri Ikeda-Matsuo; Azusa Ota; Tetsuya Fukada; Satoshi Uematsu; Shizuo Akira; Yasuharu Sasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.